Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6769529
Reference Type
Journal Article
Title
DNA methylation pattern of gene promoters of major neurotransmitter systems in older patients with schizophrenia with severe and mild cognitive impairment
Author(s)
Alelu-Paz, R; Gonzalez-Corpas, Ana; Ashour, N; Escanilla, Ana; Monje, A; Guerrero Marquez, C; Algora Weber, M; Ropero, S
Year
2015
Is Peer Reviewed?
Yes
Journal
International Journal of Geriatric Psychiatry
ISSN:
0885-6230
EISSN:
1099-1166
Volume
30
Issue
6
Page Numbers
558-565
Language
English
PMID
25044034
DOI
10.1002/gps.4182
Web of Science Id
WOS:000355985600002
Abstract
OBJECTIVE:
To analyze, in older patients with schizophrenia, the methylation status of a set of genes associated with the pathophysiology of the disorder but including anatomical, clinical, and cognitive criteria in the experimental design that, in conjunction with the epigenetic status of specific genes, allows us to derive an integrative model.
METHOD:
This study included 29 human brain samples from older schizophrenic patients with severe and mild cognitive impairment. We administered a comprehensive battery of neurocognitive tests to determine the size of the impairment across different cognitive domains. We focused our study on the analysis of the methylation pattern of 19 genes of major neurotransmitter systems using methylation-specific PCR and bisulfite genomic sequencing.
RESULTS:
Our results highlight an absence of hypermethylation and hypomethylation in older patients with schizophrenia and in healthy controls, irrespective of the degree of the cognitive deficit measured in the neuropsychological assessment (Fisher's exact test; p<0.05).
CONCLUSION:
mRNA or protein expression level differences in genes of major neurotransmitter systems that are known to be altered in schizophrenia must be because of regulatory mechanisms other than the DNA methylation of its promoter regions, although our results highlight the idea that the analysis of the epigenetic mechanisms involved in schizophrenia represents a new approach that has the possibility of uncovering molecular mechanisms of dysregulated gene expression in this complex disorder.
Keywords
epigenetics; older schizophrenia; DNA methylation; cognition
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity